US Food and Drug Administration (FDA) Approves First RSV Vaccine for Older Adults

US Food and Drug Administration (FDA) Approves First RSV Vaccine for Older Adults

Daily Current Affairs   /   US Food and Drug Administration (FDA) Approves First RSV Vaccine for Older Adults

Change Language English Hindi

Category : International Published on: May 06 2023

Share on facebook
  • The US Food and Drug Administration (FDA) has approved the first vaccine for respiratory syncytial virus (RSV) in the United States.
  • ‘Arexvy’, manufactured by GSK, is the world's first RSVvaccine for adults aged 60 years and older.
  • The vaccine was approved for people aged 60 and older after it was found 83 percent effective against diseases caused by RSV and more than 94 percent effective against severe diseases.
  • RSV causes a lower respiratory illness that is typically mild for healthy adults. But in serious cases, the virus can lead to pneumonia or bronchiolitis, which inflames airways and clogs them with mucus.
  • According to the US Centers for Disease Control and Prevention, it leads to approximately 60,000 to 120,000 hospitalizations and 6,000 to 10,000 deaths among adults 65 years of age and older.
Recent Post's
  • India and Tanzania expanded defence cooperation at the 4th JDCC meeting in Zanzibar, adding new focus on cyber, AI and air force collaboration.

    Read More....
  • Divakar Jayant assumed charge as Director General of Naval Armament, bringing over 33 years of defence service experience.

    Read More....
  • Assam sanctioned ₹50 crore to restore Koch dynasty heritage and promote cultural tourism.

    Read More....
  • India and Kyrgyzstan launched the 13th KHANJAR joint Special Forces exercise in Misamari.

    Read More....
  • IHMCL signed a pact with NFSU to strengthen cyber security in digital highway systems.

    Read More....
  • Indian climber Kabak Yano scaled Mount Aconcagua, advancing her Seven Summits mission.

    Read More....
  • The 6th Badminton Asia Team Championships started in Qingdao with India competing in both events.

    Read More....
  • Moltbook emerged as a global experiment where AI agents interact without human input.

    Read More....
  • Kerala introduced NeophyteID, an AI app for citizen-led tracking of invasive plant species.

    Read More....
  • RBI approved Vinay Tonse as YES Bank’s new MD & CEO for a three-year term.

    Read More....